Drug Type Small molecule drug |
Synonyms MENK, Menkophian, Met-enkephalin + [7] |
Target |
Mechanism Opioid receptors agonists(Opioid receptors agonists), Immunomodulators, Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
RegulationOrphan Drug (US) |
Molecular FormulaC27H35N5O7S |
InChIKeyYFGBQHOOROIVKG-FKBYEOEOSA-N |
CAS Registry58569-55-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Methionine enkephalin | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Phase 2 | US | 25 Mar 2014 | |
Ovarian Cancer | Phase 2 | US | 23 Jan 2012 | |
Hepatocellular Carcinoma | Phase 2 | - | - | |
Hepatocellular Carcinoma | Phase 2 | - | - | |
Hepatocellular Carcinoma | Phase 2 | - | - | |
HIV Infections | Phase 2 | - | - | |
HIV Infections | Phase 2 | - | - | |
HIV Infections | Phase 2 | - | - | |
Advanced Malignant Solid Neoplasm | Phase 1 | US | 01 Nov 2005 | |
Influenza, Human | Preclinical | US | - | - |
Phase 2 | 24 | cfiqdzretu(apfqhxuwai) = No adverse effects on hematologic or chemistry parameters were noted tyodcmokqi (empqluniij ) View more | Positive | 01 Mar 2010 | |||
Not Applicable | - | - | xatibiftmw(bijpnuwigo) = jwqbymqowj cqmcfrmelm (qsorpbaqbs ) View more | - | 15 Nov 2005 | ||
Not Applicable | - | Excess OGF exposure | uvrbnrqbfh(bhyrxwsqab) = bsmgpoyorf vsbxatgsix (lsooxbfpry ) View more | - | 05 Nov 2000 | ||
Naltrexone (NTX) | uvrbnrqbfh(bhyrxwsqab) = sujljlzpcq vsbxatgsix (lsooxbfpry ) View more |